查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球毛髮角化病治疗市场 - 2022-2029
市场调查报告书
商品编码
1129242

全球毛髮角化病治疗市场 - 2022-2029

Global Keratosis Pilaris Treatment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 160 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

预计毛髮角化病治疗的进展将推动市场增长。

二氧化氯化合物具有优良的抗菌消炎作用，对人体无害。它是一种高浓度的危险气体。然而，当它溶解在水中并施用于人体组织时，它会被细胞内的防御机制灭活，不会引起任何不良反应。已发现它是治疗毛髮角化病的有效清洁剂。此外，它通过中和活性氧并破坏稳定角蛋白的分子内和分子间二硫键而起到角质层分离剂的作用。它只与一些特定的氨基酸发生反应，不氧化脂质和碳水化合物等有机化合物。活性氨基酸有半胱氨酸、酪氨酸、色氨酸、蛋氨酸、脯氨酸、羟脯氨酸、组氨酸等，其生物作用大部分由半胱氨酸、蛋氨酸、酪氨酸和色氨酸组成。因此，作为毛髮角化病的治疗剂的需求不断增加。综上所述，未来毛髮角化症治疗药物的市场规模有望扩大。

与毛髮角化病治疗相关的并发症预计将阻碍市场增长。

患者经常对疾病的外观感到苦恼。患者创伤性地破坏病变导致的疤痕是另一个可能发生的问题。缺乏对使用规定的局部治疗和不操纵病变的重要性的认识是预计在预测期内阻碍市场的一些因素。

全球角化病支柱治疗市场 - 行业分析

毛髮角化病治疗市场基于波特五力、供应链分析、报销方案、产品创新和定价分析等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对医疗保健系统和市场产生了适度影响。与 SARS-CoV-2 相关的皮肤病在全球范围内呈上升趋势。黄斑疹、水疱疹、假性紫癜、毛髮角化病和荨麻疹是与这些疾病相关的五种主要模式。此外，到 2020 年，由于对非必要的医生就诊的限制和大多数国家的全面封锁，诊断和治疗率将急剧下降。美国皮肤病学会也一直在与皮肤科医生保持沟通，以限制对患有非紧急医疗问题（如毛髮角化病）的患者的访问。

此外，大流行还将扰乱供应炼和流程。许多公司将转移到其他地区以确保产品可用性并保护其供应链。因此，从上面这句话来看，市场受到了影响，预计随着经济活动的恢復，市场将迅速获得牵引力。

全球毛髮角化病治疗市场报告将提供对大约 45 多个市场数据表、40 多个数字和 160 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 毛髮角化病治疗的进展有望推动市场增长
    • 限制因素
      • 与毛髮角化病治疗相关的并发症预计会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按模态类型

  • 非处方药
  • 处方

第 8 章按治疗类型

  • 外用去角质剂
    • 乳液
    • 奶油
    • 其他
  • 类视黄醇外用剂
    • 维甲酸（Atraline、Avita、Renova、Retin A）
    • 他扎罗汀 (Avage, Tazolac)
    • 其他
  • 激光治疗
  • 其他

第 9 章按销售渠道

  • 医院药房
  • 零售药房
  • 在线药店
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 12 章公司简介

  • Neostrata Company, Inc.
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • SLMD Skincare
  • Galderma
  • Touch Skin Care
  • Nip+Fab
  • Neutrogena
  • Eucerin
  • AmLactin
  • CeraVe
  • First Aid Beauty

第 13 章全球角化病支柱治疗市场-DataM

简介目录
Product Code: DMPH5775

Market Overview

Keratosis Pilaris Treatment market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.3 % during the forecast period (2022-2029).

Keratosis pilaris is a common skin ailment that causes small bumps on your arms, legs, or buttocks. Bumps form when there is too much keratin in your skin. Moisturizers and prescription creams are used to assist and improve the appearance of the skin. By the age of 30, the problem normally goes away.

Market Dynamics

Advancement in the treatment of Keratosis Pilaris is expected to drive market growth.

Chlorine dioxide compound is a great antibacterial and anti-inflammatory substance that is non-toxic to humans. It's a dangerous gas at high concentrations. Still, when it's dissolved in water and administered to human tissue, it's inactivated by an intracellular defense mechanism, so there are no adverse effects. In keratosis pilaris, it has been discovered to be an effective cleansing agent. Moreover, it functions as a keratolytic by neutralizing reactive oxygen molecules and destroying the intramolecular and intermolecular disulfide bonds that stabilize keratin. It only reacts with a few specific amino acids and does not oxidize lipids, carbohydrates, or other organic compounds. Cysteine, tyrosine, tryptophan, methionine, proline, hydroxyproline, and histidine are among the amino acids it reacts with, with cysteine, methionine, tyrosine, and tryptophan constituting the majority of its biologic action. Therefore, there is an increased demand for the treatment of Keratosis Pilaris. Thus, from the above statements, the market is expected to drive in the forecast period.

Complications associated with Keratosis Pilaris Treatment are expected to hamper the market growth.

Patients are often distressed about the cosmetic appearance of the condition. Scarring resulting from the patient rupturing the lesions traumatically is another problem that might occur. Lack of awareness about the importance of using the prescribed topical treatments and not manipulating the lesions are some factors the market is expected to hamper in the forecast period.

Global Keratosis Pilaris Treatment Market - Industry Analysis

The keratosis pilaris treatment market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. SARS-CoV-2-related cutaneous diseases have been on the rise all over the world. Maculopapular rash, vesicular rash, pseudo-chilblain, keratosis pilaris, and urticaria are the five most common patterns associated with these disorders. Moreover, due to limits on non-essential doctor visits and complete lockdown in most countries, diagnosis and treatment rates have decreased dramatically by 2020. In addition, the American Academy of Dermatology was in constant contact with dermatologists to limit the number of patients with non-urgent medical concerns, such as keratosis pilaris, who were allowed to visit.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

Segment Analysis

Topical Exfoliates segment is expected to hold the largest market share in keratosis pilaris treatment market

The topical exfoliates segment is expected to dominate in 2021. The segment is beneficial because Keratosis pilaris normally disappears on its own over time. In the interim, you can improve the appearance of your skin using any of the many products available. If moisturizing and other self-care measures don't help, your doctor may prescribe medicated creams. For instance, Alpha hydroxy acid, lactic acid, salicylic acid, and urea-containing creams help loosen and eliminate dead skin cells. They also soften and hydrate dry skin. These creams (topical exfoliants) are available over-the-counter or with a prescription, depending on their intensity.

Moreover, the use of a medicated cream daily may help to improve the appearance of the skin. If you stop, though, the problem will return. Keratosis pilaris can linger for years, even after treatment. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global keratosis pilaris Treatment market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of Keratosis Pilaris, rising patient education among the population, advancement in the treatment of Keratosis Pilaris, high rate of adoption of solutions, increase in the number of patients with keratosis pilaris visiting the doctor, as well as new players are focusing on forming partnerships with pharmacies are some of the factors the market is expected to boost in the forecast period. For instance, The appropriate management of keratosis pilaris necessitates patient education. Patients must recognize that keratosis pilaris is a chronic illness with no cure. The physician should also inform the patient that the illness often improves without therapy over time and that treatments are purely cosmetic. Patients must understand that keratosis pilaris is frequently resistant to treatment methods.

Moreover, Keratosis pilaris causes discoloration, which can be improved with laser treatments. Laser treatments are performed by dermatologists who use a laser to target the skin. It's sometimes used to alleviate extreme inflammation and redness. It's not a cure, but it might help when creams and lotions aren't cutting it. This treatment requires numerous sessions to be effective. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the keratosis pilaris treatment market are Neostrata Company, Inc., SLMD Skincare, Galderma, Touch Skin Care, Nip + Fab, Neutrogena, Eucerin, AmLactin, CeraVe, First Aid Beauty.

Neostrata Company, Inc.:

Overview:

NeoStrata Company, Inc., located in Princeton, NJ, develops and markets a comprehensive range of clinically proven, dermatologist-developed skincare brands, including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. Polyhydroxy Acid technology is used in the company's innovative therapeutic and aesthetic dermatological solutions to fulfill the needs of all skin types. They're sold at consumer stores, doctors' clinics, and spas worldwide. Moreover, AHAs are advantageous in treating dermatological diseases and efficient in spurring prematurely aged or damaged skin to regenerate itself, revolutionizing the treatment of aging skin, according to the company's passion and vision.

Product Portfolio:

GLYCOLIC RENEWAL SERUM: This potent blend of 10% Alpha Hydroxy Acid (AHA) and antioxidants is designed to improve the texture of the skin's surface. Glycolic Acid is formulated to promote surface skin cells' exfoliation while keeping the pH at a healthy level.

The global keratosis pilaris treatment market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancement in the treatment of Keratosis Pilaris is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Complications associated with Keratosis Pilaris Treatment are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Modality Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 7.1.2. Market Attractiveness Index, By Modality Type Segment
  • 7.2. Over-the-Counter*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Prescription

8. By Treatment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 8.1.2. Market Attractiveness Index, By Treatment Type Segment
  • 8.2. Topical Exfoliates*
    • 8.2.1. Lotions
    • 8.2.2. Cream
    • 8.2.3. Others
    • 8.2.4. Introduction
    • 8.2.5. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Topical retinoids
    • 8.3.1. Tretinoin (Atralin, Avita, Renova, and Retin-A)
    • 8.3.2. Tazarotene (Avage, Tazorac)
    • 8.3.3. Others
  • 8.4. Laser treatment
  • 8.5. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 9.2. Hospital Pharmacies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Retail Pharmacies
  • 9.4. Online Pharmacies
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Neostrata Company, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. SLMD Skincare
  • 12.3. Galderma
  • 12.4. Touch Skin Care
  • 12.5. Nip + Fab
  • 12.6. Neutrogena
  • 12.7. Eucerin
  • 12.8. AmLactin
  • 12.9. CeraVe
  • 12.10. First Aid Beauty

LIST NOT EXHAUSTIVE

13. Global Keratosis Pilaris Treatment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us